Skip to main content

Table 1 Pharmacological substances included in the selected therapeutic groups and their substitution status.

From: Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years

Long-term treatments

Therapeutic group

ATC-code

Substance

Substitutable

Substitutable since*

ACE-inhibitors

C09AA

Captopril

Yes

1 October 2002

  

Enalapril

Yes

1 October 2002

  

Lisinopril

Yes

1 October 2002

  

Ramipril

Yes

1 October 2002

  

Quinapril

No

 
  

Cilazapril

No

 
  

Fosinopril

No

 
  

Trandolapril

No

 

Selective Serotonin Reuptake Inhibitors, SSRI

N06AB

Fluoxetine

Yes

1 October 2002

  

Paroxetine

Yes

1 October 2002

  

Citalopram

Yes

1 October 2002

  

Sertraline

No

 
  

Fluvoxamine

No

 
  

Escitalopram

No

 

HMG CoA-reductase inhibitors, statins

C10AA

Fluvastatin

Yes

5 February 2003

  

Simvastatin

Yes

28 March 2003

  

Pravastatin

No

 
  

Atorvastatin

No

 
  

Rosuvastatin

No

 

Short-term treatments

Nucleosides and nucleotides

J05AB

Aciclovir

Yes

1 October 2002

  

Ganciclovir

No

 
  

Famciclovir

No

 
  

Valaciclovir

No

 
  

Valganciclovir

No

 

Both short- and long-term treatments

Proton Pump Inhibitors, PPI

A10BC

Omeprazole

Yes

28 March 2003

  

Lansoprazole

No

 
  

Pantoprazole

No

 
  

Esomeprazole

No

 
  

Rabeprazole

No

 
  1. * The date when the substance became substitutable according to the Swedish Medical Products Agency given for substitutable substances.